The engineering of membrane-permeable peptides.

[1]  Tai-Huang Huang,et al.  GDSL family of serine esterases/lipases. , 2004, Progress in lipid research.

[2]  Y. Jiang,et al.  Cellular delivery of a double-stranded oligonucleotide NFκB decoy by hybridization to complementary PNA linked to a cell-penetrating peptide , 2004, Gene Therapy.

[3]  N. Allbritton,et al.  Characterization of TAT-mediated transport of detachable kinase substrates. , 2004, Biochemistry.

[4]  G. Lindblom,et al.  A molecular view on the interaction of the trojan peptide penetratin with the polar interface of lipid bilayers. , 2004, Biophysical journal.

[5]  P. Miller,et al.  3‘-Methylphosphonate-Modified Oligo-2‘-O-methylribonucleotides and Their Tat Peptide Conjugates: Uptake and Stability in Mouse Fibroblasts in Culture , 2004 .

[6]  Ronald T. Raines,et al.  Pathway for polyarginine entry into mammalian cells. , 2004, Biochemistry.

[7]  M. Eccles,et al.  Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells , 2004, FEBS letters.

[8]  H. Ohkura.  Phosphorylation: Polo Kinase Joins an Elite Club , 2003, Current Biology.

[9]  H. Hermeking.  The 14-3-3 cancer connection , 2003, Nature Reviews Cancer.

[10]  T. Muir.  Semisynthesis of proteins by expressed protein ligation. , 2003, Annual review of biochemistry.

[11]  R. Weissleder,et al.  Uptake and metabolism of a dual fluorochrome Tat-nanoparticle in HeLa cells. , 2003, Bioconjugate chemistry.

[12]  P. Garnier,et al.  Glycosyl phenylthiosulfonates (glyco-PTS): novel reagents for glycoprotein synthesis. , 2003, Organic & biomolecular chemistry.

[13]  C. R. Middaugh,et al.  Nonclassical transport proteins and peptides: an alternative to classical macromolecule delivery systems. , 2003, Journal of pharmaceutical sciences.

[14]  R. Weissleder,et al.  Arginine containing peptides as delivery vectors. , 2003, Advanced drug delivery reviews.

[15]  Joel A Swanson,et al.  Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. , 2003, Advanced drug delivery reviews.

[16]  P. Khavari,et al.  Peptide delivery to tissues via reversibly linked protein transduction sequences. , 2002, BioTechniques.

[17]  J. Reig,et al.  Direct Visualization by Confocal Fluorescent Microscopy of the Permeation of Myristoylated Peptides Through the Cell Membrane , 2002, IUBMB life.

[18]  S. Goueli,et al.  Selective in Vivo Inhibition of Mitogen-activated Protein Kinase Activation Using Cell-permeable Peptides* 210 , 2002, The Journal of Biological Chemistry.

[19]  E. Domingo,et al.  Functional Mimicry of a Discontinuous Antigenic Site by a Designed Synthetic Peptide , 2002, Chembiochem : a European journal of chemical biology.

[20]  S. Dowdy,et al.  Protein transduction technology. , 2002, Current opinion in biotechnology.

[21]  D. Mochly‐Rosen,et al.  Molecular transporters for peptides: delivery of a cardioprotective epsilonPKC agonist peptide into cells and intact ischemic heart using a transport system, R(7). , 2001, Chemistry & biology.

[22]  A. Jungbauer,et al.  The FLAG peptide, a versatile fusion tag for the purification of recombinant proteins. , 2001, Journal of biochemical and biophysical methods.

[23]  J. Gordon,et al.  The Biology and Enzymology of ProteinN-Myristoylation* 210 , 2001, The Journal of Biological Chemistry.

[24]  I. Hamachi,et al.  A general semisynthetic method for fluorescent saccharide-biosensors based on a lectin [36] , 2000 .

[25]  Ajit K. Ghosh,et al.  A novel method for sequence independent incorporation of activated/protected cysteine in Fmoc solid phase peptide synthesis , 2000 .

[26]  M. Gallop,et al.  Solid-Phase Synthesis of 3,5-Disubstituted 2,3-Dihydro-1,5-benzothiazepin-4(5H)-ones , 1999 .

[27]  J. Beattie,et al.  Cellular uptake and metabolism of myristoylated N-terminal peptides of PKA C-subunit. , 1997, Biochemical Society transactions.

[28]  W. DeGrado,et al.  Use of 2,2′-dithiobis(5-nitropyridine) for the heterodimerization of cysteine containing peptides. Introduction of the 5-nitro-2-pyridinesulfenyl group , 1996 .

[29]  H. Ploegh,et al.  A myristoylated pseudosubstrate peptide, a novel protein kinase C inhibitor. , 1993, The Journal of biological chemistry.

[30]  Richard B. Silverman,et al.  The Organic Chemistry of Drug Design and Drug Action , 1992 .

[31]  Y. Takikawa,et al.  Convenient Synthesis of Aromatic Thiosulfonates from Aromatic Sulfinates with Elemental Sulfur in Amines , 1980 .

[32]  P. Doherty,et al.  Designing cell-permeant phosphopeptides to modulate intracellular signaling pathways. , 2001, Biopolymers.

[33]  P. Bergman,et al.  An N-myristoylated protein kinase C-α pseudosubstrate peptide that functions as a multidrug resistance reversal agent in human breast cancer cells is not a P-glycoprotein substrate , 1997, Cancer Chemotherapy and Pharmacology.